ICU Medical, Inc. (ICUI)

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States Revenue	1.44B	1.53B	1.44B
United States Revenue Growth	-5.74%	6.40%	-1.37%
Europe, Middle East and Africa Revenue	407.96M	393.53M	373.57M
Europe, Middle East and Africa Revenue Growth	3.67%	5.34%	1.68%
APAC Revenue	234.75M	232.82M	241.70M
APAC Revenue Growth	0.83%	-3.67%	-6.03%
Other Foreign Countries Revenue	233.55M	223.59M	203.84M
Other Foreign Countries Revenue Growth	4.46%	9.69%	4.37%
Total Other Foreign Countries Revenue	468.30M	456.41M	445.54M
Total Other Foreign Countries Revenue Growth	2.60%	2.44%	-1.54%
Revenue (Total)	2.32B	2.38B	2.26B
Revenue (Total) Growth	-2.59%	5.44%	-0.92%

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Consumables Revenue	1.09B	1.04B	969.13M
Consumables Revenue Growth	5.17%	7.20%	-0.60%
Infusion Systems Revenue (Post-FY2022 Reporting)	679.57M	652.41M	629.04M
Infusion Systems Revenue (Post-FY2022 Reporting) Growth	4.16%	3.72%	1.88%
Vital Care Revenue	548.21M	690.77M	660.95M
Vital Care Revenue Growth	-20.64%	4.51%	-3.87%
Revenue (Total)	2.32B	2.38B	2.26B
Revenue (Total) Growth	-2.59%	5.44%	-0.92%

Updated Nov 6, 2025. Data Source: Fiscal.ai.